Evidence map›Paper›PMID 42034876›Full record

ArticleTherapeutic innovation & regulatory science2026

Clinicians' Reactions to Point-of-Care Advertising in Electronic Health Records.

Bethany L Tennant, Teresa Koenig, Sarah Bennett-Harper, Sarah Chance, Amie C O'Donoghue, Helen W Sullivan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic innovation & regulatory science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bethany L TennantWestat, 1600 Research Blvd, Rockville, MD, 20850, USA. bethanytennant@westat.com.
Teresa KoenigWestat, 1600 Research Blvd, Rockville, MD, 20850, USA.
Sarah Bennett-HarperWestat, 1600 Research Blvd, Rockville, MD, 20850, USA.
Sarah ChanceWestat, 1600 Research Blvd, Rockville, MD, 20850, USA.
Amie C O'DonoghueOffice of Prescription Drug Promotion, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Helen W SullivanOffice of Prescription Drug Promotion, Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

backgroundPharmaceutical marketers have introduced novel ways to deliver point-of-care advertising to clinicians through their electronic health record systems (EHRs) workflow. However, there is a lack of research exploring clinicians' perspectives on prescription drug promotion within EHR systems.

objectiveTo understand clinicians' awareness of, experience with, and opinions about EHR drug promotion.

methodsThis qualitative study conducted semi-structured individual interviews with 36 clinicians, including physicians, physician assistants, and hospital-based pharmacists. The interviews were conducted between March 19, 2024, and April 9, 2024, using an online videoconference platform. Participants were asked about their knowledge of EHRs that display drug promotions. Participants were shown sample EHR drug promotions in different formats, including banner ads, pop-ups, and sponsored content. For each drug promotion viewed, participants were asked questions about their overall thoughts, likes, recognition, intentions, and if they had any concerns.

resultsParticipants expressed a lack of awareness regarding the existence of prescription drug promotions that could be displayed within and around EHR systems. Overall, participants preferred promotions that offered cost savings to the patients or that they considered informative. However, many raised concerns about the ethical implications and potential distractions associated with EHR drug promotion.

conclusionsThe findings from this qualitative study contribute to the sparse literature on the clinicians' perceptions of EHR drug promotion. The findings highlight the need for further investigation into the influence of prescription drug promotions within EHRs.

Indexed as

AdvertisingAttitude of Health PersonnelElectronic Health RecordsPoint-of-Care SystemsPrescription DrugsAdultDigital HealthFemaleHumansMaleMiddle AgedPhysiciansQualitative ResearchPrescription DrugsEHRElectronic health recordsPrescription drug promotionsQualitative

Identifiers

PMID42034876
PMCPMC13182870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.